Toxin-antitoxin (TA) modules are one of the prominent determinants that triggers a persistent 28 state aiding Mycobacterium tuberculosis evasion to host generated stresses. The 79 29 characterized and putative TA systems described in M. tuberculosis are dominated by the 30 VapBC, MazEF, HigAB, RelBE and ParDE TA families, largely involved in persistence and 31 cell arrest. Hence, there is a need to maintain and conserve the TA loci in the chromosome of 32 the pathogen. It is essential to study the genomic differences of the TA systems in clinical 33 isolates along with its association to drug susceptibility patterns and lineage. In the current 34 study, the TA loci and their promoter sequences were analysed from the whole genome 35 sequence data of 74 clinical isolates. Mykrobe Predictor was used for lineage identification 36 and drug resistance predictions in the clinical isolates. Polymorphisms associated with 79.8%
profile revealed correlation of SNPs in VapBC35 with drug resistant M. tuberculosis strains 48 and SNPs in VapBC24, VapBC13 and YefM/YoeB to drug sensitive strains.
INTRODUCTION
which were determined with minimum coverage of 10x, Q-score of ≥ 20 and variant 139 On the basis of the drug susceptibility data obtained using Mykrobe Predictor, the isolates 140 were classified into Drug sensitive (DS) and Drug Resistant (DR) strains including multidrug 141 resistant TB (MDR, resistant to isoniazid and rifampicin), pre-extensively drug resistant TB 142 (pre-XDR, resistant to quinolones or any of the second line injectable in addition to isoniazid 143 and rifampicin) and extensively drug resistant TB (XDR, resistant to quinolone and second 144 line injectable along with isoniazid and rifampicin). The analysis for the presence of TA 145 system polymorphisms in the genes of the strains with different categories using paired t-test 146 revealed significant correlation between DS and DR strains detailed in observed across all isolates irrespective of their lineage. The polymorphisms found 158 exclusively or having significant association to specific lineages are presented in Table 5 .
Polymorphisms in TA systems and drug susceptibility pattern

159
With respect to the promoter sequences, polymorphisms in Rv2546-2545 (VapBC18) at a 160 single locus was found to be associated to Beijing/East Asia lineage with 88.88% (n=24) 161 prevalence rate. However, presence of additional polymorphisms at 3 other loci in the same 162 sequence was found in one isolate which belonged to the East Africa/Indian Ocean lineage.
164
Another interesting aspect in TA systems was polymorphism in the overlapping region 165 between the toxin and the antitoxin genes. The overlapping region is found in 55/79 TA 166 systems with regions varying from 1 bp to 17 bp. However, polymorphisms in the 167 overlapping region were observed in 2 TA systems namely -Rv1838c-1839c (VapBC13) and 168 Rv0595c-0596c (VapBC4), resulting in 2 different protein effects. In case of VapBC13, a 169 substitution in the toxin VapC13 leading to a change in valine to methionine was observed; 170 while in the antitoxin gene vapB13, no effect on the protein was observed. Similarly, in Rv0595c-0596c (VapBC4), a substitution of valine with methionine in the toxin VapC4 and these TA systems are significantly associated with drug sensitive strains. Also, a unique SNP 197 in Rv1102c-1103c (MazEF3) was observed in all the Beijing and Delhi Central Asia strains.
198
A previous study has linked the SNPs in Toxin-Antitoxin-Chaperon (TAC) Rv1955-1956 1957 system with Beijing strains [15] . In the present study, 77% (21/27) Beijing strains potential therapeutic tool, due to the risk of transformation into persister bacteria. With the 220 increase in the incidence of drug resistance and with limited tools to deal with such resistant strains, it may be worth looking at the TA systems to seek a solution. Such studies will be 222 beneficial in selection of TA systems for potential application in therapeutics. 
